Potential Off‐Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild‐Type FLT3 Acute Myeloid Leukemia/Myelodysplastic Neoplasms. - Chang, Shuting; Pan, Zhijuan; Zhang, Yiqun; Zhang, Ying; Sun, Jiajia; Guo, Yanru; Guo, Xinlei; Guo, Zhiping; Reikvam, Ha Kon (Case Reports in Hematology, 2025)